Opthea Ltd (CKDXF) stock
CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Opthea price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Opthea's price to sales ratio was 61.2× on Oct 19, 2026, against 280.8× a year earlier. Over the last 3 years it ranged from 61.2× to 413.9×, with a median of 215.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 61.2× | −219.6 |
| 2025 | Aug 29, 2025 | 280.8× | +0.0 |
| 2024 | Dec 31, 2024 | 280.8× | +132.2 |
| 2023 | Dec 29, 2023 | 148.6× | −265.3 |
| 2020 | Aug 31, 2020 | 413.9× | – |
See a number that looks wrong?